{"id":"furosemide-administration","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Hyperuricemia"},{"rate":null,"effect":"Ototoxicity (at high doses)"},{"rate":null,"effect":"Dehydration"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hyponatremia"}]},"_chembl":{"chemblId":"CHEMBL35","moleculeType":"Small molecule","molecularWeight":"330.75"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Furosemide is a loop diuretic that blocks the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, preventing reabsorption of sodium, potassium, and chloride. This increases urine output and reduces total body fluid volume, thereby lowering blood pressure and reducing edema. It is one of the most potent diuretics available.","oneSentence":"Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid volume.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:46:53.994Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Edema associated with congestive heart failure"},{"name":"Edema associated with hepatic cirrhosis"},{"name":"Edema associated with renal disease"},{"name":"Hypertension"},{"name":"Pulmonary edema"}]},"trialDetails":[{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":"Advanced Solid Malignancies","enrollment":41},{"nctId":"NCT07431866","phase":"PHASE1","title":"A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-18","conditions":"Healthy","enrollment":39},{"nctId":"NCT06229990","phase":"PHASE4","title":"A Protocol Based-Furosemide Stress Test to Evaluate Renal Recovery During Continuous Renal Replacement Therapy","status":"RECRUITING","sponsor":"Chiang Mai University","startDate":"2024-01-01","conditions":"Acute Kidney Injury","enrollment":80},{"nctId":"NCT07469722","phase":"PHASE2, PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":"Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect","enrollment":128},{"nctId":"NCT05305495","phase":"PHASE4","title":"Empagliflozin in Acute Heart Failure","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-12-22","conditions":"Acute Heart Failure, Chronic Kidney Diseases","enrollment":25},{"nctId":"NCT07464249","phase":"NA","title":"Comparison of the Effectiveness of Different Diuretic Therapies in the Management of Acute Heart Failure","status":"COMPLETED","sponsor":"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey","startDate":"2024-04-03","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":50},{"nctId":"NCT06167707","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2024-04-19","conditions":"Heart Failure, Fluid Overload","enrollment":21},{"nctId":"NCT07223502","phase":"PHASE3","title":"A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-12-01","conditions":"Hypertension (HTN)","enrollment":30},{"nctId":"NCT05939245","phase":"NA","title":"Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-07-24","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":40},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT07422948","phase":"NA","title":"Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-05","conditions":"Acute on Chronic Liver Failure","enrollment":113},{"nctId":"NCT06921603","phase":"NA","title":"POCUS-Guided Diuresis for Decompensated Heart Failure","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-06-29","conditions":"Heart Decompensation, Acute, Acute Kidney Injuries","enrollment":588},{"nctId":"NCT06272734","phase":"NA","title":"Reprieve System Pilot Study","status":"RECRUITING","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2024-01-23","conditions":"Acute Decompensated Heart Failure","enrollment":50},{"nctId":"NCT07167862","phase":"PHASE4","title":"Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound","status":"NOT_YET_RECRUITING","sponsor":"University of California, Irvine","startDate":"2026-06-15","conditions":"Preeclampsia, Preeclampsia Postpartum, Preeclampsia Severe or Mild","enrollment":96},{"nctId":"NCT07077772","phase":"NA","title":"Natriuresis-guided Depletion After Cardiac Surgery","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-06-25","conditions":"Cardiac Surgery, Diuresis, Congestion, Venous","enrollment":102},{"nctId":"NCT06036914","phase":"PHASE2","title":"A Study of Ultra High Dose Diuretics to Treat Heart Failure","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2023-11-27","conditions":"Heart Failure; With Decompensation","enrollment":20},{"nctId":"NCT07335900","phase":"NA","title":"A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-12-19","conditions":"Severe Aortic Valve Stenosis","enrollment":25},{"nctId":"NCT07336485","phase":"NA","title":"Forced Diuresis After Flexible Ureteroscopy for Medium-Sized Renal Stones","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-01-01","conditions":"Kidney Stones","enrollment":2000},{"nctId":"NCT05898022","phase":"PHASE4","title":"Pragmatic Research on Diuretic Management in Early BPD Pilot","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-08-17","conditions":"Bronchopulmonary Dysplasia","enrollment":19},{"nctId":"NCT06765031","phase":"NA","title":"The Role of Furosemide Stress Test in the Intensive Care Clinic","status":"RECRUITING","sponsor":"Gulhane Training and Research Hospital","startDate":"2024-11-01","conditions":"Akut Kidney Injury","enrollment":140},{"nctId":"NCT06504862","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-08-20","conditions":"Healthy","enrollment":32},{"nctId":"NCT04481789","phase":"PHASE1","title":"Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2018-10-17","conditions":"Healthy Adult Subjects","enrollment":84},{"nctId":"NCT07307131","phase":"PHASE2","title":"Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-09-01","conditions":"Cutaneous Warts, Human Papilloma Virus (HPV)","enrollment":64},{"nctId":"NCT06285760","phase":"","title":"Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)","status":"RECRUITING","sponsor":"Puerta de Hierro University Hospital","startDate":"2024-03-01","conditions":"Heart Failure, Persistent Congestion","enrollment":64},{"nctId":"NCT07286409","phase":"NA","title":"Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-01","conditions":"Respiratory Distress Syndrome, Mechanical Ventilation Complication","enrollment":344},{"nctId":"NCT07258875","phase":"NA","title":"Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery","status":"RECRUITING","sponsor":"University of Crete","startDate":"2024-11-27","conditions":"Thoracic Surgery With One-lung Ventilation, VExUS, Fluid Management","enrollment":230},{"nctId":"NCT06898515","phase":"PHASE3","title":"Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)","status":"RECRUITING","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2025-07-14","conditions":"Acute Decompensated Heart Failure","enrollment":400},{"nctId":"NCT06979726","phase":"PHASE4","title":"Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-11-20","conditions":"Heart Failure, Volume Overload","enrollment":100},{"nctId":"NCT06941415","phase":"PHASE3","title":"Bumetanide vs. Furosemide in Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Stacy Johnson","startDate":"2026-03-01","conditions":"Cirrhosis","enrollment":500},{"nctId":"NCT05779943","phase":"PHASE2","title":"Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2023-04-27","conditions":"Prostate Adenocarcinoma, Recurrent Prostate Carcinoma","enrollment":20},{"nctId":"NCT03753204","phase":"PHASE1, PHASE2","title":"Salt-Sensitivity and Immunity Cell Activation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-09-01","conditions":"High Blood Pressure, Salt; Excess, Inflammation","enrollment":20},{"nctId":"NCT07173738","phase":"PHASE1","title":"Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2018-06-11","conditions":"Pulmonary Arterial Hypertension","enrollment":44},{"nctId":"NCT04962412","phase":"","title":"Predicting Poor Outcomes of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers","status":"COMPLETED","sponsor":"Guowei Tu","startDate":"2021-05-12","conditions":"Acute Kidney Injury, Critical Illness","enrollment":3152},{"nctId":"NCT05612490","phase":"","title":"Furosemide Stress Test to Predict Successful Liberation From RRT","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2023-01-17","conditions":"Acute Kidney Injury","enrollment":52},{"nctId":"NCT07099885","phase":"NA","title":"Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2025-08-01","conditions":"Acute Heart Failure (AHF), Congestion, Venous","enrollment":90},{"nctId":"NCT05365451","phase":"EARLY_PHASE1","title":"Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters","status":"COMPLETED","sponsor":"Washington State University","startDate":"2022-04-11","conditions":"Interaction, Endogenous Biomarkers","enrollment":16},{"nctId":"NCT06092437","phase":"NA","title":"Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients","status":"RECRUITING","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-02-27","conditions":"Heart Failure Acute","enrollment":466},{"nctId":"NCT06874556","phase":"","title":"A Study of Paramedic HF Management","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-24","conditions":"Heart Failure","enrollment":75},{"nctId":"NCT05174312","phase":"NA","title":"Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2022-07-11","conditions":"Acute Decompensated Heart Failure","enrollment":100},{"nctId":"NCT07072897","phase":"NA","title":"A Study Comparing Restrictive and Liberal Fluid Therapy During Pancreatecoduodenectomy Surgery","status":"COMPLETED","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2020-05-01","conditions":"Pancreatic Cancer, Resected, Whipple Procedure","enrollment":44},{"nctId":"NCT05528588","phase":"PHASE2","title":"Furoscix in Heart Failure Patients With Diuretic Resistance","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-06-02","conditions":"Heart Failure","enrollment":70},{"nctId":"NCT06491550","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-07-15","conditions":"Healthy Participants","enrollment":91},{"nctId":"NCT07008365","phase":"PHASE3","title":"The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria Aragón","startDate":"2025-03-10","conditions":"Acute Heart Failure, Congestive Heart Failure, Intraabdominal Hypertension","enrollment":168},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT04201704","phase":"NA","title":"Effect of Giving Reduced Fluid in Children After Trauma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2018-08-27","conditions":"Critical Illness, Pediatrics, General Surgery","enrollment":250},{"nctId":"NCT04156451","phase":"NA","title":"Effect of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg in Septic Shock Patients","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-11-14","conditions":"Septic Shock","enrollment":44},{"nctId":"NCT06251713","phase":"NA","title":"Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-07-31","conditions":"Acute Kidney Injury, Cardiac Surgery, Venous Congestion","enrollment":40},{"nctId":"NCT06886191","phase":"NA","title":"PuO2 in RenalGuard Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2025-03-17","conditions":"Cardiac Surgery Subjects","enrollment":30},{"nctId":"NCT05939193","phase":"NA","title":"Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2023-07-24","conditions":"Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemotherapy, Hydration","enrollment":168},{"nctId":"NCT06362668","phase":"NA","title":"EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2024-05-17","conditions":"Acute Decompensated Heart Failure","enrollment":12},{"nctId":"NCT06852924","phase":"NA","title":"Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)","status":"RECRUITING","sponsor":"Novlead Inc.","startDate":"2023-08-10","conditions":"High Altitude Pulmonary Hypertension","enrollment":100},{"nctId":"NCT04893629","phase":"NA","title":"New Horizons for the Treatment of Cardiomyopathy in Children","status":"TERMINATED","sponsor":"Damascus University","startDate":"2021-05-20","conditions":"Cardiomyopathy","enrollment":22},{"nctId":"NCT05652322","phase":"PHASE2, PHASE3","title":"Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Jan Kochanowski University","startDate":"2022-12-07","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT05986773","phase":"PHASE4","title":"Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance","status":"TERMINATED","sponsor":"Stadtspital Zürich","startDate":"2023-10-10","conditions":"Acute Heart Failure, Diuretic Resistance","enrollment":13},{"nctId":"NCT04170855","phase":"NA","title":"Kidney Sodium Content in Cardiorenal Patients","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-10-20","conditions":"Cardio-Renal Syndrome","enrollment":50},{"nctId":"NCT05079789","phase":"PHASE3","title":"Amiloride in Nephrotic Syndrome","status":"TERMINATED","sponsor":"University Hospital Tuebingen","startDate":"2020-06-08","conditions":"Nephrotic Syndrome, Edema, Sodium Retention","enrollment":20},{"nctId":"NCT05276219","phase":"PHASE4","title":"Optimized Treatment of Pulmonary Edema or Congestion","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2023-09-14","conditions":"Pulmonary Edema, Congestive Heart Failure, Acute Heart Failure","enrollment":1104},{"nctId":"NCT06377449","phase":"NA","title":"Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients","status":"RECRUITING","sponsor":"Saint Petersburg State University, Russia","startDate":"2024-05-15","conditions":"Ischemic Heart Disease, Aortic Stenosis, Severe, Aortic Insufficiency","enrollment":186},{"nctId":"NCT06407401","phase":"PHASE3","title":"Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2024-12","conditions":"ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I","enrollment":399},{"nctId":"NCT05093621","phase":"PHASE3","title":"Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-02-08","conditions":"Heart Failure","enrollment":47},{"nctId":"NCT00690521","phase":"NA","title":"A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2004-10-26","conditions":"Congestive Heart Failure","enrollment":8},{"nctId":"NCT06630923","phase":"PHASE3","title":"PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS","status":"RECRUITING","sponsor":"Democritus University of Thrace","startDate":"2023-01-14","conditions":"Diuretics Drug Reactions, Heart Failure; With Decompensation, Albumin; Double","enrollment":250},{"nctId":"NCT06586060","phase":"NA","title":"Lung Ultrasound Guided Fluid Balance Strategy in Patients with Lung Contusion","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-10","conditions":"Lung Contusion","enrollment":100},{"nctId":"NCT03259165","phase":"PHASE2","title":"Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial","status":"TERMINATED","sponsor":"Indiana University","startDate":"2017-12-14","conditions":"Heart Failure, Heart Failure Acute, Acute Cardiac Failure","enrollment":52},{"nctId":"NCT06414759","phase":"PHASE4","title":"Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Acute Decompensated Heart Failure, Volume Overload, Edema","enrollment":110},{"nctId":"NCT03136198","phase":"PHASE2","title":"B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-07-10","conditions":"Heart Failure, Heart Failure Acute, Acute Cardiac Pulmonary Edema","enrollment":130},{"nctId":"NCT04615624","phase":"PHASE3","title":"Furosemide vs. Placebo for Severe Antepartum Hypertension","status":"COMPLETED","sponsor":"Melanie Maykin, MD","startDate":"2021-01-04","conditions":"Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications","enrollment":65},{"nctId":"NCT02055872","phase":"PHASE3","title":"Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2014-09","conditions":"Edema, Hypoproteinemia","enrollment":46},{"nctId":"NCT06024889","phase":"PHASE1, PHASE2","title":"Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.","status":"COMPLETED","sponsor":"Johannes Grand","startDate":"2023-09-01","conditions":"Acute Heart Failure","enrollment":20},{"nctId":"NCT06227702","phase":"NA","title":"Vexus-guided Fluid Management in Patients With Septic Shock After the Resuscitation Phase","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2024-02-01","conditions":"Critically Ill Patients, Septic Shock","enrollment":200},{"nctId":"NCT06218199","phase":"PHASE4","title":"Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts","status":"RECRUITING","sponsor":"Heart Center Research, LLC","startDate":"2021-07-08","conditions":"Heart Failure, Congestive","enrollment":80},{"nctId":"NCT06203236","phase":"PHASE4","title":"Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01","conditions":"Acute Heart Failure, Chronic Kidney Diseases","enrollment":300},{"nctId":"NCT01050361","phase":"NA","title":"Echocardiography Management for Patients Requiring Care for Non-Cardiac Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2010-07-28","conditions":"Cardiovascular Risk Factors","enrollment":35},{"nctId":"NCT04733547","phase":"","title":"Spectral Analysis of Central Venous Pressure Waveform","status":"COMPLETED","sponsor":"JongHae Kim","startDate":"2021-02-22","conditions":"Donor Hepatectomy, Central Venous Catheter, Hypovolemia","enrollment":60},{"nctId":"NCT02574845","phase":"PHASE1","title":"DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2015-10-12","conditions":"Healthy","enrollment":18},{"nctId":"NCT03307252","phase":"PHASE1","title":"This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-10-25","conditions":"Healthy","enrollment":45},{"nctId":"NCT06097923","phase":"NA","title":"Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)","status":"COMPLETED","sponsor":"Seoul St. Mary's Hospital","startDate":"2021-11-30","conditions":"Fluid Overload, Fluid Loss","enrollment":200},{"nctId":"NCT04343235","phase":"PHASE4","title":"Postpartum Management of Gestational Hypertensive Disorders Using Furosemide","status":"TERMINATED","sponsor":"Wright State University","startDate":"2020-05-01","conditions":"Hypertension, Pregnancy-Induced","enrollment":13},{"nctId":"NCT05287100","phase":"NA","title":"To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-01","conditions":"Cirrhosis, Liver","enrollment":35},{"nctId":"NCT05538234","phase":"","title":"Biomarkers of Kidney Function in Transplant Medicine","status":"RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2023-01-01","conditions":"Acute Kidney Injury","enrollment":30},{"nctId":"NCT04590937","phase":"PHASE1","title":"A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-10-20","conditions":"Healthy","enrollment":15},{"nctId":"NCT03362515","phase":"PHASE2","title":"Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide","status":"TERMINATED","sponsor":"Thomas Jefferson University","startDate":"2017-12-01","conditions":"Nasal Polyps","enrollment":18},{"nctId":"NCT01474200","phase":"NA","title":"Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment","status":"TERMINATED","sponsor":"Nuwellis, Inc.","startDate":"2012-01","conditions":"Heart Failure, Cardiac Failure, Acute Decompensated Heart Failure (ADHF)","enrollment":224},{"nctId":"NCT04593823","phase":"PHASE2","title":"Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2021-05-03","conditions":"Heart Failure","enrollment":63},{"nctId":"NCT05940220","phase":"PHASE3","title":"Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2023-12-30","conditions":"Heart Failure","enrollment":130},{"nctId":"NCT02575963","phase":"PHASE1, PHASE2","title":"Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients","status":"COMPLETED","sponsor":"Actinium Pharmaceuticals","startDate":"2012-10","conditions":"AML","enrollment":40},{"nctId":"NCT05933642","phase":"PHASE2, PHASE3","title":"Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2023-07-02","conditions":"Acute Kidney Injury","enrollment":132},{"nctId":"NCT01860170","phase":"PHASE1, PHASE2","title":"Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis","status":"COMPLETED","sponsor":"Corewell Health West","startDate":"2012-04","conditions":"Hematological Malignancy","enrollment":28},{"nctId":"NCT02941315","phase":"PHASE1","title":"Risk Stratification of Heart Failure in Cardiomyopathies.","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2016-12-01","conditions":"Cardiomyopathy With Unknown Etiology","enrollment":150},{"nctId":"NCT05840536","phase":"PHASE4","title":"Combination Diuretic Therapy for Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Ochsner Health System","startDate":"2014-05","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT03772262","phase":"EARLY_PHASE1","title":"Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach","status":"COMPLETED","sponsor":"Washington State University","startDate":"2018-04-05","conditions":"Interaction Drug Food","enrollment":16},{"nctId":"NCT05807152","phase":"NA","title":"Furosemide-induced Diuresis With Matched Dehydration Compared to Standard Diuretic Therapy in Patients With Acute Heart Failure and Overt Fluid Overload","status":"UNKNOWN","sponsor":"Centro Cardiologico Monzino","startDate":"2019-02-19","conditions":"Acute Decompensated Heart Failure","enrollment":170},{"nctId":"NCT02649998","phase":"NA","title":"Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF","status":"WITHDRAWN","sponsor":"Chinese University of Hong Kong","startDate":"2017-01","conditions":"Heart Decompensation","enrollment":""},{"nctId":"NCT05769738","phase":"PHASE3","title":"The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2023-03","conditions":"Chronic Obstructive Pulmonary Disease Exacerbation, COPD Exacerbation","enrollment":200},{"nctId":"NCT05594823","phase":"PHASE4","title":"Flexible vs. Fixed Diuretic Regimen in the Management of Chronic Heart Failure: A Pilot Study","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-01-03","conditions":"Heart Failure, Heart Diseases","enrollment":30},{"nctId":"NCT03458325","phase":"PHASE3","title":"Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2020-11-12","conditions":"Heart Failure","enrollment":27},{"nctId":"NCT05087940","phase":"","title":"Treatment of Resistant Hypertension: Cohort Study","status":"COMPLETED","sponsor":"Galenika AD Beograd","startDate":"2021-06-01","conditions":"Resistant Hypertension","enrollment":731},{"nctId":"NCT05599971","phase":"NA","title":"Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2023-02-22","conditions":"Plantar Wart","enrollment":45},{"nctId":"NCT02329834","phase":"PHASE2, PHASE3","title":"Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2015-04","conditions":"Heart Failure","enrollment":23},{"nctId":"NCT05631782","phase":"EARLY_PHASE1","title":"Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients","status":"COMPLETED","sponsor":"The First People's Hospital of Zunyi","startDate":"2020-11-10","conditions":"Chronic Renal Failure, Hemodialysis","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":609,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["lasix"],"phase":"marketed","status":"active","brandName":"furosemide administration","genericName":"furosemide administration","companyName":"Unity Health Toronto","companyId":"unity-health-toronto","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid volume. Used for Edema associated with congestive heart failure, Edema associated with hepatic cirrhosis, Edema associated with renal disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}